What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Action Timeline
2026-03-19
Referred to the House Committee on Energy and Commerce.
2026-03-19
Introduced in House
2026-03-19
Introduced in House
Frequently Asked Questions
Did HR.8018 pass?
HR.8018 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.8018?
HR.8018 was sponsored by Ralph Norman (R-South Carolina).
Full Bill Text
119 HR 8018 IH: Increase Support for Life-saving Endocrine Transplantation Act U.S. House of Representatives 2026-03-19 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 2d Session H. R. 8018 IN THE HOUSE OF REPRESENTATIVES March 19, 2026 Mr. Norman (for himself and Mr. Bacon ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To regulate human cadaveric islets for transplantation as organs. 1. Short title This Act may be cited as the Increase Support for Life-saving Endocrine Transplantation Act or the ISLET Act . 2. Regulation of human cadaveric islet transplants (a) In general Section 374(d)(2) of the Public Health Service Act ( 42 U.S.C. 274b(d)(2) ) is amended by striking pancreas, and inserting and pancreas, human cadaveric islets, . (b) Clarification Notwithstanding any other provision of law, none of the following terms includes human cadaveric islets: (1) The term drug , as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(g) ). (2) The term biological product , as defined in section 351(i) of the Public Health Service Act ( 42 U.S.C. 262(i) ). (3) The term human cells, tissues, or cellular or tissue-based products (HCT/Ps) , as defined in section 1271.3 of title 21, Code of Federal Regulations (or any successor regulations). (c) Regulations (1) In general Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the Secretary ) shall update regulations promulgated under parts F, G, and H of title III of the Public Health Service Act ( 42 U.S.C. 262 et seq. , 264 et seq., 273 et seq.) and the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. ), and such other regulations as the Secretary determines appropriate, to carry out the amendment made by subsection (a). (2) Report Not later than 6 months after the date of enactment of this Act, the Secretary shall report to Congress on the progress made in updating regulations as required under paragraph (1).
Loading intelligence layer…